Logotype for The Cigna Group

The Cigna Group (CI) Q1 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for The Cigna Group

Q1 2026 earnings summary

9 May, 2026

Executive summary

  • Q1 2026 revenues rose 5% year-over-year to $68.5 billion, with adjusted EPS of $7.79, up 16%, and net income up 25% to $1.65 billion, driven by strong performance in Evernorth and Cigna Healthcare.

  • Adjusted income from operations increased 12% to $2.06 billion, with diluted EPS at $6.26, and shareholders' net income at $1.7 billion.

  • Raised full-year 2026 adjusted EPS outlook to at least $30.35, reflecting confidence in sustained growth.

  • Announced leadership transition: Brian Evanko to become CEO on July 1, with David Cordani moving to Executive Chair.

  • Proactive portfolio reshaping: exiting individual exchange business after 2026 and initiating strategic review of EviCore.

Financial highlights

  • Q1 2026 revenues: $68.5 billion; adjusted EPS: $7.79, up 16% year-over-year; adjusted income from operations: $2.06 billion (+12%).

  • Pharmacy revenues: $54.0 billion (+11%); fees/other revenues: $4.4 billion (+14%); premiums: $9.8 billion (–23% due to divestiture).

  • Evernorth revenues grew 9% to $58.4 billion; pre-tax adjusted earnings up 2% to $1.5 billion.

  • Specialty and Care Services pre-tax adjusted earnings up 20% to $1.1 billion; Pharmacy Benefit Services pre-tax adjusted earnings down 28% to $394 million.

  • After-tax special items charges of $322 million ($1.22 per share) recorded in Q1; strategic optimization program costs totaled $380 million pre-tax.

Outlook and guidance

  • Full-year 2026 adjusted EPS outlook raised to at least $30.35.

  • Evernorth full-year 2026 adjusted income from operations expected at least $6.9 billion; Cigna Healthcare at least $4.525 billion.

  • Cigna Healthcare Medical Care Ratio expected between 83.7% and 84.7% for 2026.

  • Second quarter adjusted EPS expected to be ~25% of full-year outlook; MCR to be slightly above high end of full-year range due to seasonality.

  • Management expects continued growth in Evernorth and improved margins in Cigna Healthcare, with ongoing investments in client-focused initiatives and cost management.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from The Cigna Group